HCW Biologics Inc.
Developing novel immunotherapies to treat aging-related chronic inflammation.
HCWB | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 2929 N COMMERCE PKWY, 33025 MIRAMAR
- Website:
- https://hcwbiologics.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
HCW Biologics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to treat diseases linked to aging and chronic inflammation. The company's core mission is to lengthen healthspan by disrupting 'inflammaging,' the chronic, low-grade inflammation that increases with age. HCW Biologics develops proprietary immunotherapy candidates designed to address chronic inflammation through mechanisms such as inflammasome modulation and the clearance of senescent cells. Its platform generates molecules that robustly activate and expand immune cells for therapeutic applications.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all HCW Biologics Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for HCW Biologics Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for HCW Biologics Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
